| 2024年中报 | 2023年年报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|
| 营业收入(元) | ||||||||
| 抗HPV生物蛋白产品(元) | - | - | - | 4,757,770.57 | 46,702,473.02 | 36,473,538.59 | 23,001,924.55 | 9,453,115.87 |
| 重组胶原蛋白产品(元) | - | - | - | 121,343,829.04 | 333,922,421.46 | 207,245,929.78 | 125,894,880.90 | 52,785,050.41 |
| 功能性护肤品(元) | 47,975,500.61 | 75,934,381.87 | 31,165,501.39 | - | - | - | - | - |
| 医疗器械(元) | 530,695,137.99 | 679,956,005.53 | 276,631,292.49 | - | - | - | - | - |
| 原料及其他(元) | 23,818,906.86 | 24,181,313.19 | 8,504,585.32 | - | - | - | - | - |
| 其他医疗器械产品(元) | - | - | - | 1,946,421.08 | 9,478,388.41 | 7,636,810.66 | 5,252,906.08 | 2,320,591.68 |
| 营业成本(元) | ||||||||
| 抗HPV生物蛋白产品(元) | - | - | - | 882,281.19 | 6,357,932.98 | 4,899,541.96 | 2,923,071.32 | 1,151,656.36 |
| 重组胶原蛋白产品(元) | - | - | - | 10,792,643.22 | 46,569,764.96 | 31,294,262.90 | 20,683,287.69 | 7,816,486.84 |
| 功能性护肤品(元) | 16,904,690.60 | 24,458,935.33 | 11,206,335.82 | - | - | - | - | - |
| 医疗器械(元) | 29,549,262.08 | 46,404,197.35 | 20,098,134.92 | - | - | - | - | - |
| 原料及其他(元) | 4,042,493.57 | 5,828,443.19 | 3,001,263.19 | - | - | - | - | - |
| 其他医疗器械产品(元) | - | - | - | 1,196,606.98 | 3,862,821.75 | 3,089,106.65 | 1,977,486.17 | 853,846.48 |
| 毛利(元) | ||||||||
| 抗HPV生物蛋白产品(元) | - | - | - | 3,875,489.38 | 40,344,540.04 | 31,573,996.63 | 20,078,853.23 | 8,301,459.51 |
| 重组胶原蛋白产品(元) | - | - | - | 110,551,185.82 | 287,352,656.50 | 175,951,666.88 | 105,211,593.21 | 44,968,563.57 |
| 功能性护肤品(元) | 31,070,810.01 | 51,475,446.54 | 19,959,165.57 | - | - | - | - | - |
| 医疗器械(元) | 501,145,875.91 | 633,551,808.18 | 256,533,157.57 | - | - | - | - | - |
| 原料及其他(元) | 19,776,413.29 | 18,352,870.00 | 5,503,322.13 | - | - | - | - | - |
| 其他医疗器械产品(元) | - | - | - | 749,814.10 | 5,615,566.66 | 4,547,704.01 | 3,275,419.91 | 1,466,745.20 |
| 毛利率(%) | ||||||||
| 抗HPV生物蛋白产品(%) | - | - | - | 81.46 | 86.39 | 86.57 | 87.29 | 87.82 |
| 重组胶原蛋白产品(%) | - | - | - | 91.11 | 86.05 | 84.90 | 83.57 | 85.19 |
| 功能性护肤品(%) | 64.76 | 67.79 | 64.04 | - | - | - | - | - |
| 医疗器械(%) | 94.43 | 93.18 | 92.73 | - | - | - | - | - |
| 原料及其他(%) | 83.03 | 75.90 | 64.71 | - | - | - | - | - |
| 其他医疗器械产品(%) | - | - | - | 38.52 | 59.25 | 59.55 | 62.35 | 63.21 |
| 收入构成(%) | ||||||||
| 抗HPV生物蛋白产品(%) | - | - | - | 3.72 | 11.97 | 14.51 | 14.92 | 14.64 |
| 重组胶原蛋白产品(%) | - | - | - | 94.76 | 85.60 | 82.45 | 81.67 | 81.76 |
| 功能性护肤品(%) | 7.96 | 9.73 | 9.85 | - | - | - | - | - |
| 医疗器械(%) | 88.08 | 87.17 | 87.46 | - | - | - | - | - |
| 原料及其他(%) | 3.95 | 3.10 | 2.69 | - | - | - | - | - |
| 其他医疗器械产品(%) | - | - | - | 1.52 | 2.43 | 3.04 | 3.41 | 3.59 |
| 毛利构成(%) | ||||||||
| 抗HPV生物蛋白产品(%) | - | - | - | 3.36 | 12.10 | 14.89 | 15.62 | 15.17 |
| 重组胶原蛋白产品(%) | - | - | - | 95.98 | 86.21 | 82.97 | 81.83 | 82.15 |
| 功能性护肤品(%) | 5.63 | 7.32 | 7.08 | - | - | - | - | - |
| 医疗器械(%) | 90.79 | 90.07 | 90.97 | - | - | - | - | - |
| 原料及其他(%) | 3.58 | 2.61 | 1.95 | - | - | - | - | - |
| 其他医疗器械产品(%) | - | - | - | 0.65 | 1.68 | 2.14 | 2.55 | 2.68 |